Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01647282 · ClinicalTrials.gov registry record · Phase 4
Local Minocycline to Reduce Future Inflammation and Bone Loss in Periodontal Maintenance Patients
A Phase 4 study of Moderate to Advanced Chronic Periodontitis, sponsored by University of Nebraska.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
- 2
- Study locations
NCT01647282 is a Phase 4 study of Moderate to Advanced Chronic Periodontitis that has completed, run by University of Nebraska. The registered enrollment target is 60 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT01647282, a Phase 4 study of Moderate to Advanced Chronic Periodontitis, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to determine the effect of local application of minocycline microspheres on the periodontal inflammation and bone loss prevention in patients diagnosed with moderate-severe chronic periodontitis within a periodontal maintenance program.
Conditions Studied
Interventions
- DRUG locally-applied minocycline HCl (1 mg)
- PROCEDURE scaling and root planing (Sc/RP)
Study Locations (2)
Nebraska
- University of Nebraska, College of Dentistry - Lincoln
- Creighton University School of Dentistry - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2012-10-01 |
| Est. Completion | 2015-12-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01647282
The ClinicalTrials.gov registry entry for NCT01647282 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Moderate to Advanced Chronic Periodontitis appearing as the primary indexed condition, and to 2 interventions - of which locally-applied minocycline HCl (1 mg) is the first listed.
NCT01647282 reports 2 study locations spanning 1 distinct geographic area - top geographies include Nebraska.
Frequently Asked Questions
What is clinical trial NCT01647282 about?
NCT01647282 is a clinical study titled "Local Minocycline to Reduce Future Inflammation and Bone Loss in Periodontal Maintenance Patients". The purpose of this study is to determine the effect of local application of minocycline microspheres on the periodontal inflammation and bone loss prevention in patients diagnosed with moderate-severe chronic periodontitis within a periodontal maintenance program.
What is the current status of trial NCT01647282?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2012-10-01. Estimated completion is 2015-12-01.
What conditions does trial NCT01647282 study?
This clinical trial studies the following conditions: Moderate to Advanced Chronic Periodontitis.
What interventions are being tested in trial NCT01647282?
The interventions under investigation include: locally-applied minocycline HCl (1 mg) (DRUG), scaling and root planing (Sc/RP) (PROCEDURE).
Who is sponsoring clinical trial NCT01647282?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01647282 being conducted?
This trial has 2 study locations across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.